SEC Comment Letter 0000000000-23-000747 to GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373) (GWLL)
GOLDENWELL BIOTECH, INC. (GWLL) (CIK 0001800373)
Date: Jan. 23, 2023 · CIK: 0001800373 · Accession: 0000000000-23-000747
AI Filing Summary & Sentiment
File numbers found in text: 000-56275
Letter
United States securities and exchange commission logo January 23, 2023 Shuang Liu Chief Executive Officer, President, and Director Goldenwell Biotech, Inc. 2071 Midway Drive Twinsburg, OH 44087 Re:Goldenwell Biotech, Inc. Form 10-K for the Fiscal Year ended December 31, 2021 Filed April 1, 2022 File No. 000-56275 Dear Shuang Liu: We issued comments to you on the above captioned filing on October 19, 2022. As of the date of this letter, these comments remain outstanding and unresolved. We expect you to provide a complete, substantive response to these comments by February 6, 2023. If you do not respond, we will, consistent with our obligations under the federal securities laws, decide how we will seek to resolve material outstanding comments and complete our review of your filing and your disclosure. Among other things, we may decide to release publicly, through the agency's EDGAR system, all correspondence, including this letter, relating to the review of your filings, consistent with the staff's decision to publicly release comment and response letters relating to disclosure filings it has reviewed. Please contact Joe Klinko at (202) 551-3824 or Lily Dang at (202) 551-3867 with any questions regarding this letter or the comments in the letter referenced above. Sincerely, Division of Corporation Finance Office of Energy & Transportation
Show Raw Text
United States securities and exchange commission logo
January 23, 2023
Shuang Liu
Chief Executive Officer, President, and Director
Goldenwell Biotech, Inc.
2071 Midway Drive
Twinsburg, OH 44087
Re:Goldenwell Biotech, Inc.
Form 10-K for the Fiscal Year ended December 31, 2021
Filed April 1, 2022
File No. 000-56275
Dear Shuang Liu:
We issued comments to you on the above captioned filing on October 19, 2022. As of
the date of this letter, these comments remain outstanding and unresolved. We expect you to
provide a complete, substantive response to these comments by February 6, 2023.
If you do not respond, we will, consistent with our obligations under the federal securities
laws, decide how we will seek to resolve material outstanding comments and complete our
review of your filing and your disclosure. Among other things, we may decide to release
publicly, through the agency's EDGAR system, all correspondence, including this letter, relating
to the review of your filings, consistent with the staff's decision to publicly release comment and
response letters relating to disclosure filings it has reviewed.
Please contact Joe Klinko at (202) 551-3824 or Lily Dang at (202) 551-3867 with any
questions regarding this letter or the comments in the letter referenced above.
Sincerely,
Division of Corporation Finance
Office of Energy & Transportation